Showing results (51-60 of 189) with videos related to

Sort By:
Pageof 19
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Mastectomy or tamoxifen as initial therapy for operable breast cancer in elderly patients: 5-year follow-upJ F Robertson, I O Ellis, C W Elston, et al.
Hormone Research|January 1, 1989
Zoladex in advanced breast cancerJ F Robertson, R I Nicholson, K J Walker, et al.
International Journal of Cancer|June 16, 2001
Phosphorylation of ERK1/2 mitogen-activated protein kinase is associated with poor response to anti-hormonal therapy and decreased patient survival in clinical breast cancerJ M Gee, J F Robertson, I O Ellis, et al.
Gut|August 1, 1993
Effect of histamine on the growth of human gastrointestinal tumours: reversal by cimetidineS A Watson, L J Wilkinson, J F Robertson, et al.
The International Journal of Biological Markers|January 1, 1996
Oestrogen and progesterone receptors as prognostic variables in hormonally treated breast cancerJ F Robertson, P M Cannon, R I Nicholson, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 11, 1997
A one-year audit of 255 operable breast cancersD O McCarthy, R W Blamey, J F Robertson, et al.
European Journal of Cancer (Oxford, England : 1990)|February 21, 1998
The clinical relevance of static disease (no change) category for 6 months on endocrine therapy in patients with breast cancerJ F Robertson, P C Willsher, K L Cheung, et al.
Endocrine-Related Cancer|October 12, 1999
Involvement of steroid hormone and growth factor cross-talk in endocrine response in breast cancerR I Nicholson, R A McClelland, J F Robertson, et al.
Breast Cancer Research and Treatment|March 23, 2001
Selection of primary breast cancer patients for adjuvant endocrine therapy--is oestrogen receptor alone adequate?K L Cheung, R I Nicholson, R W Blamey, et al.
The British Journal of Surgery|December 1, 1989
Combined endocrine effects of LHRH agonist (Zoladex) and tamoxifen (Nolvadex) therapy in premenopausal women with breast cancerJ F Robertson, K J Walker, R I Nicholson, et al.
Pageof 19